Research shows that 81% of employers acknowledge the interest of employees in GLP-1 coverage, but only 25% actually offer it, leading to a significant disparity between employee demand and employer offerings
Policy changes like the Inflation Reduction Acts $2,000 out-of-pocket (OOP) cap for Medicare Part D beneficiaries may offer some relief, as patients who reach the cap pay $0 thereafter, but they also risk prompting payers to tighten coverage for high-cost drugs, especially those indicated for obesity
Tirzepatide is currently FDA-approved for specific indications and is widely used in obesity medicine programs across the country
Liraglutide has also been seen to inhibit tau-hyperphosphorylation in DR, thus protecting RGCs from degeneration [91]
Studies in human and mouse islets lacking functional K ATP channels have demonstrated that the effect on plasma glucose is at least in part mediated by inhibition of insulin secretion resulting from lower cytoplasmic cAMP levels
The puffy white powder can be stored at room temperature until youre ready to reconstitute it with bacteriostatic water